Status:
RECRUITING
Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults
Lead Sponsor:
Pusan National University Yangsan Hospital
Conditions:
Liver Diseases
Eligibility:
All Genders
19-75 years
Phase:
NA
Brief Summary
The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Panax Ginseng C.A. Mey Extract on liver function in adults for 8 weeks.
Detailed Description
Previous studies have indicated that Panax Ginseng C.A. Mey Extract may have the ability to improve liver function. Therefore, the investigators conduct a randomized, double-blind, placebo-controlled ...
Eligibility Criteria
Inclusion
- ALT ranging from upper limit of reference to three times of upper limit
Exclusion
- Abnormal liver or renal function (i.e., serum aminotransferase activity \> 3 times of upper limit of reference range and serum creatinine concentrations \> 1.2 mg/dL)
- Diabetes (diagnosed clinically or fasting glucose level \> 126 mg/dL)
- History of viral hepatitis or cancer
- Uncontrolled hypertension
- History of serious cardiac disease such as angina or myocardial infarction
- History of gastrectomy
- History of medication for psychiatric disease
- Administration of oriental medicine including herbs within the past 4 weeks
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03775837
Start Date
December 1 2018
End Date
December 31 2025
Last Update
June 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Integrated Research Institute for Natural Ingredients and Functional Foods
Yangsan, South Korea, 50612